Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||
---|---|---|---|---|---|---|
fig.5.a
Macrì S et al. (2016) |
Xla Wt + hmga2 MO
NF13 (in situ hybridization) |
|
||||
fig.S6.b
Macrì S et al. (2016) |
Xla Wt + hmga2 MO
NF13-18 (in situ hybridization) |
|
||||
fig.5.b
Macrì S et al. (2016) |
Xla Wt + hmga2 MO
NF16 (in situ hybridization) |
|
||||
fig.4. u
Macrì S et al. (2016) |
Xla Wt + msx1
NF16 (in situ hybridization) |
|
||||
fig.6.a
Macrì S et al. (2016) |
Xla Wt + msx1
NF16 (in situ hybridization) |
|
||||
fig.4. r
Macrì S et al. (2016) |
Xla Wt + msx1 MO
NF16 (in situ hybridization) |
|
||||
fig.6.b
Macrì S et al. (2016) |
Xla Wt + pax3
NF16 (in situ hybridization) |
|
||||
fig.4.d
Wang C et al. (2015) |
Xla Wt + ets1
NF17 (in situ hybridization) |
|
||||
fig.4.j
Wang C et al. (2015) |
Xla Wt + ets1
NF17 (in situ hybridization) |
|
||||
fig.5.o
Wang C et al. (2015) |
Xla Wt + ets1
NF17 (in situ hybridization) |
|